You are here:
Publication details
157P Real-world outcomes of checkpoint inhibitors guided by molecular testing and tumor mutation burden (TMB): Results from Czech national precision medicine network study GENESIS
| Authors | |
|---|---|
| Year of publication | 2025 |
| Type | Conference abstract |
| Citation | |
| Attached files |